Vai al contenuto principale della pagina

Inflammation and Allergy Drug Design



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Izuhara K Visualizza persona
Titolo: Inflammation and Allergy Drug Design Visualizza cluster
Pubblicazione: Chicester, : Wiley, 2011
Edizione: 1st ed.
Descrizione fisica: 1 online resource (346 p.)
Disciplina: 615.7
615.794
615/.7
Soggetto topico: Allergy - Treatment
Allergy -- Treatment
Antiallergic agents
Anti-Allergic Agents
Anti-Inflammatory Agents
Anti-inflammatory agents
Drug Design
Drugs - Design
Drugs -- Design
Hypersensitivity - drug therapy
Hypersensitivity -- drug therapy
Antiallergic agents - Treatment
Allergy - Design
Drugs
Drug Discovery
Therapeutics
Immune System Diseases
Therapeutic Uses
Diseases
Pharmacologic Actions
Investigative Techniques
Chemistry, Pharmaceutical
Chemical Actions and Uses
Pharmacology
Chemistry
Biological Science Disciplines
Natural Science Disciplines
Drug Therapy
Hypersensitivity
Health & Biological Sciences
Pharmacy, Therapeutics, & Pharmacology
Altri autori: HolgateStephen T  
Wills-KarpMarsha  
Note generali: Description based upon print version of record.
Nota di contenuto: Inflammation and Allergy Drug Design; Contents; Contributors; Preface; Part I: Cells contributing to the pathogenesis of allergic diseases in the respiratory tract; 1: Novel anti-inflammatory drugs based on targeting lung dendritic cells and airway epithelial cells; 2: Role of Th2 cells in the allergic diathesis; 3: Importance of Th17-and Th1-associated responses for the development of asthma; 4: Regulatory T cells; 5: A role for natural killer T-cell subsets in the pathogenesis of various allergic disorders; 6: Regulatory roles of B cells in allergy and inflammation; 7: Mast cells
8: Eosinophils9: Basophils in inflammation and allergy drug design; 10: Epithelial cells; 11: Fibroblasts; 12: Airway smooth muscle cells; Part II: Cytokines contributing to the pathogenesis of allergic diseases in the respiratory tract; 13: Interleukin 4, interleukin 13, and interleukin 9; 14: Interleukin 3, interleukin 5, and granulocyte-macrophage colony-stimulating factor; 15: Interleukin 15, interleukin 17, and interleukin 25; 16: Thymic stromal lymphopoietin; 17: Interleukin 10; 18: Tumor necrosis factor alpha; 19: Profibrotic and angiogenic factors in asthma; 20: Chemokines
21: Epithelial growth factorsPart III: Other mediators contributing to the pathogenesis of allergic diseases in the respiratory tract; 22: Prostanoids; 23: Leukotrienes; 24: Proteases in allergy; 25: Toll-like receptors; Index
Sommario/riassunto: This book educates the reader on the molecular and cellular mechanism of allergic diseases in the respiratory tract covering all aspects, from its immunological basis to its application in drug development. In contrast to other books, this book focuses on well-known and newly-emerging cells, cytokins, and mediators involved in the pathogenesis of allergic diseases in the respiratory tract. In particular, this book emphasises the findings of novel drug targets. This book allows immunologists, allergologists and researchers in the pharmaceutical industry to learn and appreciate the target biolog
Titolo autorizzato: Inflammation and Allergy Drug Design  Visualizza cluster
ISBN: 1-283-20493-2
9786613204936
1-4443-4668-7
1-4443-4666-0
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910139614403321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui